Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02627339 · ClinicalTrials.gov registry record
Building a Database of Results From People Without Eye Problems
A clinical trial, sponsored by Wills Eye.
- Completed
- Registry status
- 208
- Enrollment target
NCT02627339: Completed study, sponsored by Wills Eye.
NCT02627339 is a clinical trial that has completed, run by Wills Eye. The registered enrollment target is 208 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02627339 has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
The purpose of this study is to build a database of results from a new test that measures contrast sensitivity (the Spaeth-Richman Contrast Sensitivity Test (SPARCS)). Contrast sensitivity is an important part of your ability to see. When contrast sensitivity decreases, you are less able to see objects and detect motion. For instance, if you have decreased contrast sensitivity, you might be less able to read, see in the dark, drive, hit a ball, or walk safely. Decrease in contrast sensitivity leads to a decrease in quality of life.
Primary Outcome
Results from each eyes response to the contrast sensitivity test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-08 |
What the finished NCT02627339 record still lists
NCT02627339 is an observational study that tracks outcomes without assigning an intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02627339 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02627339 about?
NCT02627339 is a clinical study titled "Building a Database of Results From People Without Eye Problems". The purpose of this study is to build a database of results from a new test that measures contrast sensitivity (the Spaeth-Richman Contrast Sensitivity Test (SPARCS)). Contrast sensitivity is an important part of your ability to see. When contrast sensitivity decreases, you are less able to see obje...
What is the current status of trial NCT02627339?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2012-08. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02627339?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia